|
|
||||||||
J Thorac Cardiovasc Surg 2005;129:1348-1352
© 2005 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Md.
Received for publication August 2, 2004; revisions received September 25, 2004; accepted for publication October 11, 2004. * Address for reprints: Grover M. Hutchins, MD, Department of Pathology, The Johns Hopkins Hospital, Pathology B-100, 600 N Wolfe St, Baltimore, MD 21287-6901. (Email: ghutchi{at}jhmi.edu).
| Abstract |
|---|
|
|
|---|
METHODS: We reviewed the clinical and pathologic features of 9 autopsied patients having undergone the Fontan procedure, with special attention given to their liver pathology.
RESULTS: The 9 patients died from a few hours to 18 years after the Fontan operation. Chronic passive congestion was seen in 7 patients, and 4 patients surviving 4 to 18 years also had cardiac cirrhosis. Hepatic adenoma in the setting of cardiac cirrhosis was found in a patient surviving for 9 years. One patient surviving for 18 years had hepatocellular carcinoma superimposed on cardiac cirrhosis. Rupture of the hepatoma in this case led to fatal hemorrhage.
CONCLUSION: The study shows that chronically increased hepatic venous pressure from the Fontan procedure might lead to chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.
|
In 1971, Fontan and Baudet1 reported on a highly effective palliative operation for infants born with tricuspid atresia. With improved management strategies of intensive care units, there has been a shift in focus in patients undergoing the Fontan procedure from survival to long-term morbidity and quality of life.2 There is still significant morbidity after the completion of these operations, including myocardial dysfunction,3,4 diminished exercise capacity,5 arrhythmias,6 protein-losing enteropathy,7 thrombotic complications,8 somatic growth retardation,9 neoaortic valve root dilatation and insufficiency,10 and the possibility of suboptimal neurodevelopmental outcome.11 We have observed a 24-year-old patient at autopsy with tricuspid atresia who had undergone a Fontan operation at 6 years of age and experienced hepatocellular carcinoma (HCC), which had caused his death. This case prompted us to review our autopsy files for patients having undergone the Fontan procedure to assess the nature of their liver pathology.
| Materials and Methods |
|---|
|
|
|---|
|
|
|
|
| Results |
|---|
|
|
|---|
Of the 9 cases reviewed, there were 4 cases in which the histologic diagnosis of CC was made by the criteria described above (patients 69). By definition and examination, those 4 patients had 4+ ratings of CPC, whereas only 2 patients (patients 7 and 9) showed any evidence of CLN. Their analysis accurately depicts the physiologic state in the patients described here.
The hepatic changes related to CPC observed in this series of 9 patients correlates nearly directly with the amount of time each patient lived with the Fontan procedure. Likewise, a correlate can be drawn between the right atrial pressures and the extent of CPC, as depicted in Table 2. In addition, 2 of the 3 patients with the longest survivals were found to have neoplastic transformation associated with their CC.
Patient 7 died at the age of 14 years and had lived for 9 years after the Fontan procedure. The gross and histologic features of the hepatic nodule found at autopsy are consistent with a hepatic adenoma (Figure 2). The immunohistochemical staining supported this diagnosis.
|
1-antitrypsin deficiency. | Discussion |
|---|
|
|
|---|
Hepatic CPC and CLN are commonly encountered at autopsy and imply a circulatory abnormality. CPC is usually a consequence of right-sided heart failure, whereas CLN is usually a consequence of severe hypotension or shock. Severe prolonged CPC can eventually lead to the development of CC, which, histologically, in the early stages of the disease process, exhibits a distinguishing reverse lobulation pattern in which fibrous septa form bridges between central veins. In long-standing or severe cases, the cell loss and collapse of normal architecture might spread to incorporate some portal tracts. However, there are rarely portal inflammatory cells or bile ductular proliferation, which helps distinguish CC from the cirrhoses more commonly encountered in adults.13 Its incidence is unknown, but the most frequent causes include ischemic heart disease (31%), cardiomyopathy (23%), valvular heart disease (23%), primary lung disease (15%), and pericardial disease (8%). The clinical diagnosis of the condition is difficult because there have been no conclusive studies correlating liver function tests or other serum markers to the disease process.14
In our opinion the relationship between increased right-sided pressures and CC is now clear. Lemmer and colleagues15 reported a case of a 15-year-old girl who, on postmortem examination, had evidence of CC 5 years after a modified Fontan procedure for tricuspid atresia. The case report is very similar to that of the patient described in our article, who went on to have HCC (patient 9). Mean right atrial pressures after successful modified Fontan procedures are usually in the range of 8 to 20 mm Hg. The patients described in our series clearly fall within this range, and those with marked CC are in the upper echelon of this range. Previous studies have shown that increased venous pressures have been shown to be associated with increased morbidity and mortality in patients undergoing the Fontan procedure.16 In 1990, Ho and associates17 presented a case report of a 50-year-old man who had lived with constrictive pericarditis since the age of 23 years. He experienced long-standing hepatic venous congestion. On routine examination, he was found to have a firm hepatic mass in the right lobe of the liver and, after various studies, was found to have an enlarged liver with macronodular cirrhosis. He then underwent a laparotomy and wedge resection of the mass, which revealed HCC. He was, like our patient 9, found to have no other potential underlying causes for his liver cirrhosis or HCC, other than chronically increased right-sided pressures. The authors therefore concluded that this patient was the first reported case of an HCC associated with CC.
We now report what we believe to be the second such reported case but in a patient population that can be monitored closely for known increase of right-sided pressures. Given observations presented here, patients who undergo the Fontan procedure or similar operations must be carefully followed for the development of chronic liver disease, which could ultimately result in HCC and a fatal outcome.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. A. Feinstein, D. W. Benson, A. M. Dubin, M. S. Cohen, D. M. Maxey, W. T. Mahle, E. Pahl, J. Villafane, A. B. Bhatt, L. F. Peng, et al. Hypoplastic left heart syndrome current considerations and expectations. J. Am. Coll. Cardiol., January 3, 2012; 59(1 Suppl): S1 - S42. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. John, D. J. Driscoll, C. A. Warnes, S. D. Phillips, and F. Cetta The Use of Oral Budesonide in Adolescents and Adults With Protein-Losing Enteropathy After the Fontan Operation Ann. Thorac. Surg., October 1, 2011; 92(4): 1451 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Fredenburg, T. R. Johnson, and M. D. Cohen The Fontan Procedure: Anatomy, Complications, and Manifestations of Failure RadioGraphics, March 1, 2011; 31(2): 453 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Baek, E. J. Bae, J. S. Ko, G. B. Kim, B. S. Kwon, S. Y. Lee, C. I. Noh, E.-A. Park, and W. Lee Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors Heart, November 1, 2010; 96(21): 1750 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Burch Is heart transplantation for adult congenital heart disease an appropriate use of a scarce resource? Heart, August 1, 2010; 96(15): 1172 - 1173. [Full Text] [PDF] |
||||
![]() |
M. Beghetti Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies Heart, June 1, 2010; 96(12): 911 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakata, Y. Fujimoto, K. Hirose, M. Osaki, Y. Tosaka, Y. Ide, M. Tachi, and K. Sakamoto Fontan completion in patients with atrial isomerism and separate hepatic venous drainage Eur J Cardiothorac Surg, June 1, 2010; 37(6): 1264 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Lacour-Gayet, C. J. Lanning, S. Stoica, R. Wang, B. A. Rech, S. Goldberg, and R. Shandas An Artificial Right Ventricle for Failing Fontan: In Vitro and Computational Study Ann. Thorac. Surg., July 1, 2009; 88(1): 170 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Camposilvan, O. Milanesi, G. Stellin, A. Pettenazzo, L. Zancan, and L. D'Antiga Liver and Cardiac Function in the Long Term After Fontan Operation Ann. Thorac. Surg., July 1, 2008; 86(1): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Friedrich-Rust, C. Koch, A. Rentzsch, C. Sarrazin, P. Schwarz, E. Herrmann, A. Lindinger, U. Sarrazin, T. Poynard, H.-J. Schafers, et al. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 560 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-B. Hsu, F.-Y. Lin, N.-K. Chou, W.-J. Ko, N.-H. Chi, and S.-S. Wang Heart transplantation in patients with extreme right ventricular failure Eur J Cardiothorac Surg, September 1, 2007; 32(3): 457 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H Kiesewetter, N. Sheron, J. J Vettukattill, N. Hacking, B. Stedman, H. Millward-Sadler, M. Haw, R. Cope, A. P Salmon, M. C Sivaprakasam, et al. Hepatic changes in the failing Fontan circulation Heart, May 1, 2007; 93(5): 579 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Khairy, N. Poirier, and L.-A. Mercier Univentricular Heart Circulation, February 13, 2007; 115(6): 800 - 812. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |